Clinical Trial Update: Study Evaluating PD-0299685 for the Treatment of Vasomotor Symptoms (Hot Flashes / Flushes) Associated With Menopause [Phase 2]

View source ↗

Summary

Pfizer completed a Phase 2 trial evaluating PD-0299685 for vasomotor symptoms (hot flashes) associated with menopause.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause

Drugs mentioned

• PD 0299685

Snippet

Sponsor: Pfizer | Conditions: Hot Flashes | Phase 2 | Status: COMPLETED